The role of MGuard stent in primary coronary angioplasty

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomaterials Science

Background:

• No-reflow phenomenon, characterized by inadequate tissue-level reperfusion post-percutaneous coronary intervention (PCI), is common in acute myocardial infarction and linked to adverse outcomes.
• Pathogenesis involves microvascular dysfunction and distal embolization of thrombus/plaque debris during PCI, especially stent deployment.
• Existing strategies to prevent no-reflow are insufficient, highlighting the need for novel devices.

Purpose of the Study:

• To review and discuss the available data on the MGuard stent.
• To evaluate the MGuard stent's efficacy in ameliorating tissue reperfusion by reducing distal embolization.
• To focus on the specific application of the MGuard stent in primary PCI for acute myocardial infarction.

Main Methods:

• The MGuard stent is a balloon-expandable bare metal stent with an outer polyethylene terephthalate (PET) mesh designed to entrap embolic material.
• The stent functions by trapping thrombus and plaque debris between its struts and the vessel wall upon expansion.
• Clinical data regarding the MGuard stent's use in high-embolic-risk lesions, including acute coronary syndromes and vein grafts, were reviewed.

Main Results:

• The MGuard stent is designed to reduce distal embolization, a key factor in the no-reflow phenomenon.
• The PET mesh aims to capture thrombus and plaque debris, potentially improving myocardial reperfusion.
• The device has been evaluated in lesions associated with high embolic risk, suggesting potential benefits in specific PCI scenarios.

Conclusions:

• The MGuard stent presents a mechanical approach to mitigate distal embolization during PCI.
• Its design may offer an advantage in improving tissue reperfusion and reducing no-reflow incidence.
• Further data, particularly on its use in primary PCI, are crucial for establishing its role in managing acute myocardial infarction.